Another involved disease in CRISPR-Cas9 research was Duchenne muscular dystrophy (DMD), a severe X-linked myopathy caused by mutations in the human DMD gene which results in a defective dystrophin protein. The gene discussed is DMD; the disease is Duchenne muscular dystrophy.